Avricore Health Inc. AVCRF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 137.90K | 104.00K | 374.50K | 1.37M | 2.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 137.90K | 104.00K | 374.50K | 1.37M | 2.21M |
| Cost of Revenue | 186.30K | 188.20K | 211.40K | 775.90K | 1.27M |
| Gross Profit | -48.60K | -84.40K | 163.10K | 589.70K | 946.70K |
| SG&A Expenses | 789.40K | 918.90K | 1.05M | 1.17M | 1.37M |
| Depreciation & Amortization | 2.90K | 3.70K | 1.40K | 3.30K | 2.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 978.60K | 1.11M | 1.26M | 1.95M | 2.64M |
| Operating Income | -840.70K | -1.01M | -884.20K | -582.20K | -426.00K |
| Income Before Tax | -1.29M | -1.43M | -1.34M | -1.17M | -1.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.29 | -1.43 | -1.34 | -1.17 | -1.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.29M | -1.43M | -1.34M | -1.17M | -1.03M |
| EBIT | -840.70K | -1.01M | -884.20K | -582.20K | -426.00K |
| EBITDA | -767.80K | -910.10K | -771.70K | -419.60K | -207.10K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 408.74M | 405.16M | 405.16M | 405.11M | 404.22M |
| Average Diluted Shares Outstanding | 408.74M | 405.16M | 405.16M | 405.11M | 404.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |